Lakshmanan M, Schaffer A, Robbins J, Reynolds J, Norton J. A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer. Clin Nucl Med 1988; 12:866–869.
Ain KB, Dewitt PA, Gardner TG, Berryman SW. Low-iodine tube-feeding diet for iodine-131 scanning and therapy. Clin Nucl Med 1994; 19:504–507.
Hamburger JI, Desai P. Mannitol augmentation of I-131 uptake in the treatment of thyroid carcinoma. Metabolism 1966; 15:1055–1058.
Hamburger JI. Diuretic augmentation of I-131 uptake in inoperable thyroid cancer. N Engl J Med 1969; 280:1091–1094.
Maruca J, Santner S, Miller KI. Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: concise communication. J Nucl Med 1984; 25:1089–1093.
EANM procedure guidelines for therapy with Iodine-131. Eur J Nucl Med Mol Imaging 2003; 30:BP27–BP31.
Beyer KH, Fehr DM, Gelarden RT, White WJ, Lang CM, Vesell ES. Hydrochlorothiazide-induced131I excretion facilitated by salt and water. J Clin Pharmacol 1981; 21:201–212.
Tepmongkol S. Enhancement of radioiodine uptake in hyperthyroidism with hydrochlorothiazide: a prospective randomised control study. Eur J Nucl Med 2002; 29:1307–1310.
Jackson G. Depletion regimens for radioiodine therapy of thyroid carcinoma. J Nucl Med 1985; 26:962.
Ohtaki S, Moriya S, Suzuki H, Horiuchi Y. Nonhormonal iodine escape from the normal and abnormal thyroid gland. J Clin Endocrinol 1967; 27:728–739.